Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority 2024-12-03 00:08
2024 Medtec Attracts Over 80,000 Industry Attendees, Helping China's Medical Device Sector Step into a New Era of Quality Development 2024-12-02 23:00
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity 2024-12-02 16:30
Witsbb Launches Major New Product! Elderberry Yeast β-glucan Drink Boosts Health for Sensitive Children 2024-12-02 12:52
George Clinical Welcomes Tony Proctor as Chief Financial Officer 2024-12-02 08:15
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong 2024-12-02 07:40
When ancient cures meet smart tech: Level up your health 2024-12-01 19:34
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China 2024-11-30 09:00
Life-Space Wins Prestigious 62nd Australian Export Awards 2024-11-29 16:00
"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts 2024-11-29 13:30
2024 Global Youth Powerhouse Summit in Hong Kong: Global Leaders and Young Professionals Address Innovation and Economic Development 2024-11-29 13:02
Ping An Wins Sixth Director of the Year Award and Inaugural Climate Governance Award from the Hong Kong Institute of Directors 2024-11-29 10:56
Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore 2024-11-29 10:00
Microbio Appoints Paul Brennan as Chair of the Board 2024-11-29 06:30
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:30
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients 2024-11-28 17:22
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List 2024-11-28 16:59
Own Your Story with AwarerHOME™ 2024-11-28 16:34
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List 2024-11-28 13:43
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country 2024-11-28 13:04
1 2 3 4 5 799